Navigation Links
Ben-Gurion U. and UChicago research collaboration targets water resource innovations
Date:6/26/2013

oved swiftly following the signing of an initial memorandum of understanding in Chicago on March 8, 2013 to explore a research partnership that would innovate water production and purification technologies to meet a growing thirst for fresh water resources globally. Leading the efforts are Matthew Tirrell, the Pritzker Director of UChicago's Institute for Molecular Engineering, and Moshe Gottlieb, BGU's Frankel Professor of Chemical Engineering.

For its part, the Institute for Molecular Engineering will commit tens of millions of dollars to the molecular engineering of water resources over the next decade. The institute is pursuing the molecular engineering of water resources as one of five emerging research themes, with plans to hire up to six faculty members specializing in this area. BGU researchers will have a significant presence at Hyde Park to further facilitate the collaborations.

"The Institute for Molecular Engineering aims to bring molecular-level science to technological problems of global importance," Tirrell said. "Water technology clearly meets that standard, and the institute brings new ideas for materials, membranes, biotechnologies, and catalytic technologies, among other approaches, that could address major needs in this domain."

Tirrell's and Gottlieb's teams met for two days in Israel in April to explore their mutual interests in water chemistry, materials science, flow in soils and other porous substances, microbiology, and nanotechnology. The first day of meetings took place on BGU's main campus in Beer-Sheva. The researchers reconvened for a second day at BGU's Sede Boqer campus, site of the Zuckerberg Institute for Water Research.

The Israeli government founded BGU with a mandate to spearhead the development of the Negev Desert. BGU has worked at the forefront of water-related research for more than four decades, having developed several innovative technologies in the field. Work at the Zuckerberg Institut
'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Oncologists are stressed and have difficulty discussing death with patients -- Ben-Gurion U. study
2. Ben-Gurion U. and Fox Chase Cancer Center awarded NIH measles grant
3. Obama calls Ben-Gurion U. brain research a great idea
4. Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug
5. Ben-Gurion U. establishes stem cell research fund in honor of inventor Jordan Baruch
6. Ben-Gurion University team in prestigious DARPA Robotics Challenge to develop disaster response robot
7. Preeclampsia poses a significant long-term health risk according to new research from Ben-Gurion U.
8. Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
9. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
10. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
11. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... , June 23, 2015   Valencell, ... announced the results of a recent study that ... on the wrist during activity. In a study ... was compared along with the Apple Watch against ... measuring heart rate during activity. The study demonstrated ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und ... QGEN ; Frankfurt Prime Standard: QIA) hat heute in ... Produktlinie Investigator ® für ... Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... CLEAR Program is Back and Oberthur Technologies Remains a Key Partner -- CHANTILLY, Virginia, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed ...
... SEATTLE, Wash. November 18, 2010 The Paul ... advance important neuroscience and cellular engineering research. The Allen ... and laboratories in Washington, California, Massachusetts and New York. ... paid over three years. "A year ...
... teaching space and Earth sciences, there,s a world of information ... K-12 teachers to bring it into the classroom. The ... grant to professors Paul Ruscher and Alejandro Gallard for a ... a series of courses to be offered to undergraduate and ...
Cached Biology News:The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 2The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 3The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 4The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 5The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 6The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 7The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 8The CLEAR Program is Back and Oberthur Technologies Remains a Key Partner 9First Allen Distinguished Investigators named 2First Allen Distinguished Investigators named 3FSU researchers helping K-12 teachers bring science down to Earth 2
(Date:6/30/2015)... June 30, 2015  Today, Americord Registry, one of the ... Andrew Horne , a partner at Kirkland & Ellis LLP, ... Logo - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are ... Board," says Martin Smithmyer , CEO of Americord. "He ... career that will assist Americord,s growth and vision." ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
(Date:6/30/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... company focused on the development of autologous cell ... Phase 1/2 clinical trial of RCT-01, being tested ... has been enrolled and their tissue biopsy sent ... is comprised of non-bulbar dermal sheath (NBDS) cells ...
(Date:6/30/2015)... ... June 30, 2015 , ... Cannavoices , Inc., ... unprecedented digital video and broadcast initiative. Produced by filmmakers, the multi-platform initiative aims ... legal medical cannabis stories ever assembled. , Cannavoices profiles Advocates, Patients, Entrepreneurs, ...
Breaking Biology Technology:Americord Registry Announces Andrew Horne as Advisory Board Member 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 2Cannavoices Launches a Legal Medical Cannabis Documentary Initiative 3
... Wednesday, October,22, 2008, Wyeth (NYSE: WYE ) will ... will hold a one-hour conference call with,research analysts at ... and others may listen to the call live or ... be accessed by visiting our website,at http://www.wyeth.com ...
... Coleman to Lead Scientific Operations, NAPLES, Fla., ... ETHANOL(TM), the most advanced third generation biofuels,technology, today ... as Chief,Science Officer. Dr. Coleman, currently the Vice-Principal ... has over 20 years of,experience in the fields ...
... MEETING, Pa., Sept. 8 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: ... Company will present at the following conference:, ... the Grand Hyatt Hotel in Beijing on ... present at 10:20 AM local time. ...
Cached Biology Technology:Algenol Biofuels Appoints Chief Science Officer 2BMP Sunstone Announces Participation in September Investor Conference 2
MOUSE ANTI DUCK IgY LIGHT CHAIN...
Kit for Detection of Mitochondrial Membrane Potential...
For the quantitative determination of canine Interleukin 10,(IL-10) concentrations in cell culture supernates, canine serum,and plasma....
...
Biology Products: